R.PR
REGISTERED-PRINCIPAL REGISTER
09/04/2024
Voltar para busca
Dado oficial do USPTO
LYMPHOMAP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LYMPHOMAP
ST13
US500000090523038Classe
9, 35, 38, 42, 44
Pedido
90523038
Registro
7355878
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
35
Atualização mais recente
10/04/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 35, 38, 42, 44
Data de depósito
10/02/2021
Data de registro
09/04/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/04/2024
Última transação
10/04/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
21/11/2022
Primeiro uso no comércio
24/11/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Long Island City, NY, US
Examinador
FIONDA, LAURA ELIZABETH
Unidade examinadora
L80
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
LYMPHOMAP Inc.
LYMPHOMAP, Inc.
Representantes
Ranjini Acharya PILLSBURY WINTHROP SHAW PITTMAN LLP
Classificação técnica
Classes Nice
Classe 9Classe 35Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable computer programs using artificial intelligence for use in software development and machine learning in the field of healthcare; Recorded computer software using artificial intelligence for use in software development and machine learning in the field of healthcare; Software as a Medical Device (SaMD)downloadablefor diagnosing and treating cancer; Software as a Medical Device (SaMD)recordedfor diagnosing and treating cancer
Classe 35
Business collaboration servicesproviding a national computer-based networking web site for health care and medical researchers and educators to collaborate across disciplines to help improve health care education and medical education; Promoting collaboration within the scientificresearch and medical communities to achieve advances in the field of healthcare; Promoting the exchange of information and resources within the scientific research and medical communities to achieve advances in the field of healthcare; Providing an on-line database providing business intelligence in the fields of medical devicespharmaceuticals and life sciences
Classe 38
Videoconferencing services
Classe 42
Application service provider (ASP) featuring software using artificial intelligence for use in software development and machine learning in the field of healthcare; Medical and scientific research in the field of cancer treatment and diagnosis; Providing online non-downloadable computer programs for use in cancer diagnosis; Providing a website featuring non-downloadable software using artificial intelligence for use in software development and machine learning in the field of healthcare; Providing information about medical and scientific research via a website; Providing on-line non-downloadable software using artificial intelligence for use in cancer treatment and diagnosis; Software as a service (SAAS) services featuring software using artificial intelligence for use in cancer treatment and diagnosis; Software as a service (SAAS) services featuring software using artificial intelligence for use in software development and machine learning in the field of healthcare; Technology consultation in the field of artificial intelligence
Classe 44
Medical assistance services in the nature of medical information provided to medical professionals from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; Providing a website featuring information in the field of the diagnosis and treatment of cancer; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via devices that feed information to the website that is processedexchanged and accessed in real-time by users; Providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions
Publicações
Histórico de despachos e eventos da marca no USPTO.
35 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/04/2024
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/03/2024
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/03/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/03/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/03/2024
ALIE
ASSIGNED TO LIE
05/03/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
13/09/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
17/05/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
22/02/2023
GNRT
NON-FINAL ACTION E-MAILED
22/02/2023
CNRT
SU - NON-FINAL ACTION - WRITTEN
22/02/2023
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/01/2023
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/01/2023
IUAF
USE AMENDMENT FILED
08/12/2022
EISU
TEAS STATEMENT OF USE RECEIVED
08/12/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
27/05/2022
EX1G
SOU EXTENSION 1 GRANTED
25/05/2022
EXT1
SOU EXTENSION 1 FILED
25/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
25/05/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/12/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/10/2021
PUBO
PUBLISHED FOR OPPOSITION
19/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/09/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/09/2021
XAEC
EXAMINER'S AMENDMENT ENTERED
11/09/2021
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/09/2021
GNEA
EXAMINERS AMENDMENT E-MAILED
11/09/2021
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/09/2021
GNRT
NON-FINAL ACTION E-MAILED
11/09/2021
CNRT
NON-FINAL ACTION WRITTEN
11/09/2021
DOCK
ASSIGNED TO EXAMINER
05/09/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/05/2021
NWAP
NEW APPLICATION ENTERED
15/02/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LYMPHOMAP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.